Allspring Global Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-516,920
Closed -$168M 2558
2024
Q1
$168M Sell
516,920
-102,188
-17% -$25.1M 0.26% 86
2023
Q4
$118M Sell
619,108
-26,526
-4% -$5.01M 0.2% 122
2023
Q3
$129M Buy
645,634
+170,369
+36% +$40.3M 0.23% 99
2023
Q2
$136M Sell
475,265
-6,169
-1% -$1.71M 0.22% 107
2023
Q1
$104M Buy
481,434
+156,344
+48% +$30.5M 0.17% 141
2022
Q4
$66.8M Sell
325,090
-114,939
-26% -$29.1M 0.11% 227
2022
Q3
$122M Sell
440,029
-154,031
-26% -$39.2M 0.22% 108
2022
Q2
$114M Sell
594,060
-241,876
-29% -$42.7M 0.19% 137
2022
Q1
$173M Sell
835,936
-107,911
-11% -$17.8M 0.22% 112
2021
Q4
$168M Buy
+943,847
New +$186M 0.19% 140

Other funds holding SWAV

Allspring Global Investments's SWAV Position: Q2 2024 in Review

Allspring Global Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 516,920 shares — an estimated $168M sold.

Allspring Global Investments first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $173M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Allspring Global Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 516,920 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $168M.
  • Allspring Global Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Shockwave Medical, Inc. Common Stock position peaked at $173M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.